A Multicenter, Prospective, Randomized, Double-Blind, Placebo-Controlled, Dose Titration Study of Nebivolol Monotherapy in Hispanic Patients With Stage 1 or Stage 2 Hypertension.
Phase of Trial: Phase IV
Latest Information Update: 21 Dec 2010
At a glance
- Drugs Nebivolol (Primary)
- Indications Essential hypertension; Hypertension
- Focus Therapeutic Use
- Sponsors Forest Laboratories
- 23 Jul 2010 Results presented at the 25th Annual Scientific Meeting of the American Society of Hypertension in May 2010.
- 05 May 2010 Results presented at the 2010 annual meeting of the American Society of Hypertension.
- 01 May 2010 Primary endpoint 'Diastolic blood pressure' has been met.
Most Recent Events
Table of Contents
- At a glance
- Trial Overview
- Trial Details
- Trial Centres
- Trial History